BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7475890)

  • 1. Central mu opioids mediate differential control of urine flow rate and urinary sodium excretion in conscious rats.
    Kapusta DR; Dzialowski EM
    Life Sci; 1995; 56(14):PL243-8. PubMed ID: 7475890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central mu opioid receptor-mediated changes in renal function in conscious rats.
    Kapusta DR; Obih JC; Dibona GF
    J Pharmacol Exp Ther; 1993 Apr; 265(1):134-43. PubMed ID: 8097241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ).
    Kapusta DR; Sezen SF; Chang JK; Lippton H; Kenigs VA
    Life Sci; 1997; 60(1):PL15-21. PubMed ID: 8995537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats.
    Cabral AM; Varner KJ; Kapusta DR
    J Pharmacol Exp Ther; 1997 Aug; 282(2):609-16. PubMed ID: 9262322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
    Kapusta DR; Jones SY; DiBona GF
    J Pharmacol Exp Ther; 1991 Jul; 258(1):111-7. PubMed ID: 1677034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
    Kapusta DR; Obih JC
    J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia.
    Cabral AD; Kapusta DR; Kenigs VA; Varner KJ
    Am J Physiol; 1998 Dec; 275(6):R1867-74. PubMed ID: 9843875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats.
    Sezen SF; Kenigs VA; Kapusta DR
    J Pharmacol Exp Ther; 1998 Oct; 287(1):238-45. PubMed ID: 9765343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of TAPP, a highly selective mu-opioid agonist.
    Gutkowska J; Schiller PW
    Br J Pharmacol; 1996 Sep; 119(2):239-44. PubMed ID: 8886404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
    Musabayane CT; Forsling ML; Balment RJ
    Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors?
    Paakkari P; Paakkari I; Vonhof S; Feuerstein G; Sirén AL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):544-50. PubMed ID: 8394909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics.
    Meariman JK; Sutphen JC; Gao J; Kapusta DR
    Hypertension; 2022 Feb; 79(2):379-390. PubMed ID: 34852633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.
    Perucca J; Bichet DG; Bardoux P; Bouby N; Bankir L
    J Am Soc Nephrol; 2008 Sep; 19(9):1721-31. PubMed ID: 18596120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mannitol on antidiuretic and natriuretic actions of ADH in rats.
    Yu CC; Chen SM; Young TK
    Chin J Physiol; 1993; 36(3):181-6. PubMed ID: 8194394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male rats.
    Gutkowska J; Jankowski M; Mukaddam-Daher S; McCann SM
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):483-8. PubMed ID: 10618444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
    Negri L; Lattanzi R; Tabacco F; Melchiorri P
    Br J Pharmacol; 1998 May; 124(2):345-55. PubMed ID: 9641552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
    Ledderhos C; Mattson DL; Skelton MM; Cowley AW
    Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the hypophysis in the renal responses upon stimulation of the brain osmoreceptor].
    He XR; Shi L; Wang WH; Yao T
    Sheng Li Xue Bao; 1992 Jun; 44(3):215-21. PubMed ID: 1455253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin B receptor antagonism in the rat renal medulla reduces urine flow rate and sodium excretion.
    Guo X; Yang T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1001-5. PubMed ID: 16741038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.